FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely, to methods for interpreting the results of laboratory analyzes, and can be used as a method for predicting the volume of cytoreductive surgery in patients with advanced ovarian cancer after completion of the third course of neoadjuvant chemotherapy. Method involves determining the concentration of two quantitative levels of CA125 and HE4 markers, and if CA125>535 U/ml and/or HE4>205 pmol/L, only suboptimal or non-optimal cytoreduction will be achieved.
EFFECT: use of the claimed method in clinical practice makes it possible to predict the maximum achievable volume of cytoreduction during subsequent surgical intervention and personalize the tactics of treating patients, in particular, if necessary, increase the number of courses of neoadjuvant chemotherapy.
1 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING DURATION OF DISEASE-FREE INTERVAL AFTER COMPLETION OF PRIMARY TREATMENT OF PATIENTS WITH OVARY CANCER | 2018 |
|
RU2676702C2 |
| METHOD FOR PREDICTION OF PROBABILITY OF POSSIBLE EXECUTION OF OPTIMUM CYTOREDUCTIVE OPERATION IN PATIENTS WITH DISSEMINATED FORMS OF OVARIAN CANCER | 2017 |
|
RU2637399C1 |
| METHOD FOR DETERMINING THE EFFECTIVENESS OF CHEMOTHERAPY WITH PLATINUM PREPARATIONS IN III-IV STAGE OVARIAN CANCER | 2020 |
|
RU2738167C1 |
| METHOD FOR ASSESSING PRIMARY RESPONSE TO COMBINED CHEMOTHERAPY OF SPORADIC OVARIAN CANCER OF STAGES III AND IV | 2021 |
|
RU2769543C2 |
| METHOD FOR PREDICTING RECURRENCE OF SEROUS OVARIAN CARCINOMA | 2020 |
|
RU2749361C1 |
| METHOD FOR PREDICTION OF NEOADJUVANT CHEMOTHERAPY EFFECTIVENESS IN PATIENTS WITH DISSEMINATED FORMS OF OVARIAN CANCER | 2017 |
|
RU2637410C1 |
| METHOD FOR PREDICTION OF OVARIAN CANCER PERITONEAL PROPAGATION | 2019 |
|
RU2722654C1 |
| METHOD FOR PREDICTION OF RISK OF TUMOUR PROGRESSION IN PATIENTS WITH OVARIAN CANCER | 2023 |
|
RU2816339C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF ASCITIC-INFILTRATIVE OVARIAN CANCER AND ABDOMINAL TUBERCULOSIS | 2015 |
|
RU2585959C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NEOPLASMS OF OVARIES | 2018 |
|
RU2686180C1 |
